Operating Income: The income after operating expenses.
Curanex Pharmaceuticals Inc (CURX) had Operating Income of $-0.95M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-0.95M |
|
-- |
|
-- |
|
$0.95M |
|
|
Operating Income |
$-0.95M |
$-0.00M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.95M |
|
$-0.94M |
|
25.60M |
|
25.60M |
|
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$14.42M |
|
-- |
|
$0.06M |
|
$14.48M |
|
$0.19M |
|
-- |
|
-- |
|
$0.19M |
|
$14.29M |
|
$14.29M |
|
$14.29M |
|
28.34M |
|
| Cash Flow Statement Financials | |
$-9.63M |
|
-- |
|
$15.31M |
|
$0.15M |
|
$5.83M |
|
$5.68M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
77.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-9.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.68% |
|
-6.68% |
|
-6.59% |
|
-6.68% |
|
$0.50 |
|
$-0.38 |
|
$-0.38 |
|